NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Bajaj Healthcare Gets CDSCO Nod for Suvorexant Phase III Clinical Trials
Bajaj Healthcare Limited has received formal approval from the CDSCO to conduct Phase III Clinical Trials and Bioequivalence Studies for Suvorexant Tablets. This approval, granted on December 31, 2025, follows an earlier recommendation by the Subject Expert Committee for Neurology & Psychiatry. Suvorexant is a medication used to treat insomnia, representing an expansion into specialized therapeutic areas. Successful completion of these trials is a prerequisite for commercial launch in India.
முக்கிய அம்சங்கள்
CDSCO approval granted on Dec 31, 2025, for Suvorexant Clinical Trials and Bioequivalence Study.Follows previous Subject Expert Committee (SEC) recommendation from October 04, 2025.The drug targets the Neurology & Psychiatry segment, specifically for insomnia treatment.Enables the company to proceed with critical Phase III trials required for market entry.
👀 கவனிக்க வேண்டியவை
Investors should monitor the progress and timelines of these clinical trials as they are a key milestone for product commercialization. Success in this specialized segment could enhance the company's margin profile.
Waaree Renewable Bags EPC Order Worth INR 96.51 Cr for 39.80 MWp Solar Project
Waaree Renewable Technologies Limited has secured a Letter of Award for a turnkey solar EPC project from a domestic private company. The project involves the development of a 28.60 MWac (39.80 MWp) ground-mounted solar power plant. The total contract value is approximately INR 96.51 Crores, excluding taxes. This project is slated for completion within the financial year 2026-27, providing healthy revenue visibility for the company.
முக்கிய அம்சங்கள்
Awarded EPC contract for a 28.60 MWac / 39.80 MWp ground-mount solar projectTotal order value is approximately INR 96.51 Crores excluding taxesProject execution is scheduled for completion during the financial year 2026-27The contract was awarded by a domestic private limited company on a turnkey basis
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's execution pace and margin maintenance as it continues to grow its order book. This win reinforces Waaree's strong position in the domestic solar EPC market.
Waaree Energies Secures Major 1500 MW Solar Module Order for FY 2026-27
Waaree Energies has secured a substantial order for the supply of 1500 MW of solar modules from a prominent domestic power utility. The contract includes 1000 MW of Domestic Content Requirement (DCR) modules and 500 MW of Non-DCR modules. Scheduled for delivery in FY 2026-27, this order provides significant long-term revenue visibility for the company. This win underscores Waaree's competitive edge and strong positioning in the Indian renewable energy manufacturing sector.
முக்கிய அம்சங்கள்
Total order capacity of 1500 MW solar modules secured from a renowned domestic entityOrder breakdown includes 1000 MW DCR and 500 MW Non-DCR modulesExecution and supply timeline set for the Financial Year 2026-27The contract is a one-time domestic order with no related party interest
👀 கவனிக்க வேண்டியவை
This order strengthens the company's order book and provides clear growth visibility into 2027. Investors should maintain a positive outlook while monitoring the company's execution capabilities and margin maintenance.
Share India Securities Allots 3,500 NCDs Worth ₹35 Crores via Private Placement
Share India Securities Limited has approved the allotment of 3,500 Secured, Listed, and Rated Non-Convertible Debentures (NCDs). Each NCD carries a face value of ₹1,00,000, resulting in a total capital raise of ₹35 Crores. The allotment was finalized by the Finance Committee on December 31, 2025, following a series of prior disclosures. This move is part of the company's strategy to secure debt financing on a private placement basis to support its financial services operations.
முக்கிய அம்சங்கள்
Allotment of 3,500 Secured, Listed, Rated, and Redeemable Non-Convertible Debentures (NCDs).Face value of each NCD is ₹1,00,000, aggregating to a total value of ₹35 Crores.The securities are fully paid-up and were issued on a private placement basis.The Finance Committee meeting concluded within 30 minutes on December 31, 2025.
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's debt-to-equity ratio and the cost of this debt to ensure it remains within sustainable limits. This is a routine fundraise for a financial services firm to manage liquidity and growth.
MT Educare Reports Default of ₹32.33 Cr; Company Continues Under Insolvency Process (CIRP)
MT Educare Limited has disclosed a default in the repayment of principal and interest totaling ₹32.33 crores to lenders including Axis Bank and Prudence ARC. The company has been under the Corporate Insolvency Resolution Process (CIRP) since December 16, 2022, following an order by the NCLT Mumbai Bench. Beyond direct borrowings, the company faces invoked corporate guarantees amounting to ₹23.99 crores for subsidiary and associated entities. The Resolution Professional is currently managing the company and verifying claims from secured financial creditors.
முக்கிய அம்சங்கள்
Total outstanding borrowings from banks and financial institutions amount to ₹32.33 crores.Default includes ₹16.44 Cr principal to Prudence ARC and ₹7.65 Cr principal to Axis Bank.Invoked corporate guarantees total ₹7.3 Cr for Sri Gayatri Education Society and ₹16.69 Cr for Lakshya Forum.The company has been under CIRP since December 2022, with a new Resolution Professional appointed in January 2024.A claim of ₹49.72 crore from Shamrao Vithal Co-op Bank remains under legal dispute at the NCLAT.
👀 கவனிக்க வேண்டியவை
Investors should exercise extreme caution as the company is undergoing insolvency proceedings, which typically results in significant or total loss for equity shareholders. Monitor NCLT developments regarding the approval of any resolution plan or liquidation orders.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Waaree Renewable Secures Contract Enhancement to 35 MWp; Total Value Rs 102.93 Cr
Waaree Renewable Technologies Limited (WAAREERTL) has announced an enhancement of an existing EPC contract for a ground-mount solar power project. The project capacity has been scaled up from 30 MWp to 35 MWp, increasing the total contract value by Rs 12.64 crore to a total of Rs 102.93 crore. The scope includes turnkey Engineering, Procurement, and Construction (EPC) along with Operation and Maintenance (O&M) services. The project is slated for completion during the 2026-27 financial year, contributing to the company's long-term revenue visibility.
முக்கிய அம்சங்கள்
Capacity increased from 30 MWp to 35 MWp for a ground-mount solar project.Total order value revised upwards from Rs 90.29 Cr to Rs 102.93 Cr (excluding taxes).Incremental order value of Rs 12.64 Cr added to the existing contract.Project execution and completion scheduled for the financial year 2026-27.Client is a leading domestic manufacturer in the pig iron and seamless tubes industry.
👀 கவனிக்க வேண்டியவை
This order enhancement strengthens WAAREERTL's position in the solar EPC market and provides clear revenue visibility for FY27. Investors should maintain a positive outlook while tracking the company's execution pace and quarterly margin performance.
Waaree Energies Appoints Jignesh Rathod as CEO-Designate; Amit Paithankar to Step Down
Waaree Energies has announced a planned leadership transition with Mr. Jignesh Rathod appointed as CEO-Designate effective December 29, 2025. He will officially take over as CEO on May 16, 2026, following the resignation of Mr. Amit Paithankar, who is leaving to co-found a new venture. Mr. Rathod is an internal veteran who has been with the company since 2007 and has over 18 years of experience in manufacturing and operations. This long transition period and internal promotion are designed to ensure strategic continuity and operational stability.
முக்கிய அம்சங்கள்
Mr. Jignesh Rathod appointed as CEO-Designate immediately, taking full charge as CEO on May 16, 2026.Outgoing CEO Mr. Amit Paithankar to serve a transition period until May 15, 2026.Mr. Rathod brings 18+ years of experience and has been a key part of Waaree since November 2007.The transition aims to maintain momentum in scaling production capacities and driving operational efficiencies.The board highlighted that internal succession ensures leadership continuity and strong governance.
👀 கவனிக்க வேண்டியவை
Investors should view this as a stable transition given the appointee's long tenure and internal expertise. No immediate change in strategy is expected, but monitor the execution of expansion projects during the handover period.
Waaree Energies Commences 3.05 GW Solar Inverter Production in Gujarat
Waaree Energies' wholly-owned subsidiary, Waaree Power Private Limited, has officially commenced commercial operations at its new manufacturing facility in Sarodhi-Valsad, Gujarat. The facility consists of two solar inverter production lines, each with an annual capacity of 1.525 GW, resulting in a total capacity of 3.05 GW. This expansion into inverter manufacturing strengthens the company's vertical integration and product portfolio within the solar energy value chain. Operations at the facility began on December 29, 2025, marking a significant milestone in the company's growth strategy.
முக்கிய அம்சங்கள்
Commencement of commercial production at the Sarodhi-Valsad facility in Gujarat on December 29, 2025.Total annual manufacturing capacity of 3.05 GW for solar inverters.Facility features two production lines with an individual capacity of 1.525 GW each.Project executed through wholly-owned subsidiary Waaree Power Private Limited.
👀 கவனிக்க வேண்டியவை
This capacity addition is a positive development for long-term growth and margin expansion through vertical integration. Investors should monitor the ramp-up of this facility and its contribution to the company's top-line in the coming quarters.
Amara Raja Shareholders Approve ESOS 2025 and Trust-Based Share Acquisition
Amara Raja Energy & Mobility Limited has received shareholder approval for its new Employee Stock Option Scheme (ESOS) 2025 via a postal ballot. All four special resolutions, including the grant of options to subsidiary employees and the secondary acquisition of shares through a Trust route, were passed with a requisite majority. While the overall approval rate was approximately 88.45%, there was notable institutional dissent with about 23.7% of institutional votes cast against the resolutions. This move is intended to enhance employee retention and align their interests with the company's long-term growth.
முக்கிய அம்சங்கள்
All 4 special resolutions passed with over 88.4% majority on December 25, 2025.Total votes polled amounted to 12.03 crore, representing 65.74% of the total share capital.Institutional investors cast 1.38 crore votes (23.7%) against the ESOS 2025 proposal.The company is now authorized to provide funds to the ESOS Trust for secondary market share purchases.The scheme extends to employees of unlisted subsidiaries both within and outside India.
👀 கவனிக்க வேண்டியவை
Investors should monitor the financial impact of the funding provided to the ESOS Trust and the potential for minor equity dilution. The significant institutional dissent warrants a closer look at the specific terms of the ESOP scheme in the annual report.
Saregama to Acquire 28-49.9% Stake in Bhansali Productions for ₹325 Crores
Saregama India Limited has announced a strategic investment of ₹325 crores in Bhansali Productions via Compulsorily Convertible Preference Shares (CCPS), targeting a 28% to 49.9% stake by 2028. The deal grants Saregama exclusive rights to all future film music from the production house, which is expected to constitute 30-40% of its Hindi film music content. To fund this and optimize operations, Saregama will exit its own film production business, releasing ₹150-175 crores in working capital. The investment is expected to be EPS accretive by FY27 and involves no debt.
முக்கிய அம்சங்கள்
Initial investment of ₹325 crores for a significant minority stake, with an option to increase to 51% after March 2030.Secures exclusive music rights for all future Bhansali films, eliminating competitive bidding and controlling acquisition costs.Bhansali Productions reported strong FY25 financials with ₹304 Cr revenue and ₹45 Cr PAT.Saregama to wind down its own film production over 3-5 quarters, freeing up ₹150-175 Cr in capital.Sanjay Leela Bhansali is creatively locked to the production house as part of the deal terms.
👀 கவனிக்க வேண்டியவை
Investors should view this as a strategic positive that secures a premium content pipeline and improves margin profiles by avoiding bidding wars. Monitor the progress of upcoming high-profile releases like 'Love & War' to gauge the immediate impact on the music segment.
TTK Healthcare Appoints Former TTK Prestige CFO V Sundaresan as Independent Director
TTK Healthcare has appointed Mr. V Sundaresan as an Additional Independent Director for a five-year term effective December 22, 2025. Mr. Sundaresan is a veteran professional with nearly 40 years of experience, including a 30-year tenure within the TTK Group where he served as the CFO of TTK Prestige Ltd. The appointment is subject to shareholder approval via a postal ballot process, with voting concluding on January 24, 2026. His deep expertise in corporate finance, audit, and internal controls is expected to enhance the company's governance framework.
முக்கிய அம்சங்கள்
Appointment of Mr. V Sundaresan as Additional Independent Director for a 5-year term starting December 22, 2025Appointee previously served as CFO of TTK Prestige Ltd and has nearly 40 years of leadership experience in finance and auditShareholder approval to be sought through Postal Ballot with remote e-voting from December 26, 2025, to January 24, 2026Final results of the postal ballot and director appointment confirmation expected by January 28, 2026
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive governance move, bringing in a seasoned financial expert familiar with the group's operations. No immediate portfolio changes are required.
Waaree Energies Confirms 300 MW Solar Module Supply Order from Sembcorp SPV
Waaree Energies has clarified news reports confirming a 300 MW solar module supply order from Green Infra Clean Wind Technology Private Limited, a Sembcorp SPV. The contract was signed on October 23, 2025, but was not previously disclosed as the company deemed it part of its normal course of business and not a material event under SEBI regulations. The company maintains that recent share price movements are market-driven and that no unpublished price-sensitive information is pending disclosure. This clarification validates the company's strong order pipeline in the renewable energy sector.
முக்கிய அம்சங்கள்
Confirmed supply contract for 300 MW of solar modules with a Sembcorp subsidiary.Contract was executed on October 23, 2025, as part of regular business operations.Company clarified that the order did not meet the materiality threshold for mandatory disclosure at the time of signing.Management confirmed no undisclosed price-sensitive information is currently pending.Clarification issued in response to Exchange queries following news reports on December 18, 2025.
👀 கவனிக்க வேண்டியவை
Investors should take the confirmation of the 300 MW order as a positive indicator of the company's execution capabilities and order book health. The stock remains a key play in the Indian solar manufacturing space, though the 'routine' nature of this large order suggests high internal growth expectations.
Waaree Energies Incorporates Step-Down Subsidiary Hydro Bloom Energy for IPP Projects
Waaree Energies has announced the incorporation of a new step-down subsidiary, Hydro Bloom Energy Private Limited, effective December 18, 2025. This new entity is 100% owned by Waaree Forever Energies Private Limited, which is itself a wholly-owned subsidiary of Waaree Energies. The subsidiary is established as an Independent Power Producer (IPP) to facilitate and hold specific power projects. While the entity currently has nil turnover, it represents a strategic move to scale the company's power project portfolio.
முக்கிய அம்சங்கள்
Incorporation of Hydro Bloom Energy Private Limited as a 100% step-down subsidiary.The entity will operate within the Independent Power Producer (IPP) industry segment.Purpose of the new company is to facilitate and hold specific power projects under the IPP framework.The subsidiary was registered with the Registrar of Companies, Mumbai, on December 18, 2025.Current turnover of the newly incorporated entity is Nil as operations are yet to commence.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive structural expansion that prepares the company for future project execution in the IPP space. Monitor future announcements regarding specific power contracts or projects assigned to this new subsidiary.
Waaree Energies Incorporates Two Step-Down Subsidiaries for IPP Power Projects
Waaree Energies has announced the incorporation of two new step-down subsidiaries, Zephyr Green Power Private Limited and Jal Surya Power Private Limited, through its wholly-owned subsidiary Waaree Forever Energies Private Limited. These entities are established as Independent Power Producers (IPP) to facilitate and hold specific power projects. Both companies were incorporated on December 18, 2025, and are currently in the pre-operational stage with nil turnover. This structural expansion indicates the company's intent to scale its renewable energy generation portfolio and manage specific projects under dedicated entities.
முக்கிய அம்சங்கள்
Incorporation of two 100% owned step-down subsidiaries on December 18, 2025Subsidiaries named Zephyr Green Power Private Limited and Jal Surya Power Private LimitedEntities will operate as Independent Power Producers (IPP) for specific power projectsMove facilitates the holding and management of future renewable energy assetsBoth entities are newly incorporated with zero initial turnover
👀 கவனிக்க வேண்டியவை
This is a positive structural development for long-term growth in the IPP segment. Investors should monitor for upcoming project wins or capacity additions associated with these new entities to gauge future revenue potential.
Share India Securities Shareholders Approve $50 Million FCCB Issuance
Share India Securities has received shareholder approval at its Extra-Ordinary General Meeting to raise up to USD 50 million through Foreign Currency Convertible Bonds (FCCBs). The fundraising can occur in one or more tranches and may be denominated in USD, INR, or other currencies. The specific terms and conditions, including conversion price and interest rates, will be finalized by the company's Finance Committee at the time of issuance. This capital raise is intended to strengthen the company's balance sheet for future growth initiatives.
முக்கிய அம்சங்கள்
Shareholders approved raising up to USD 50 million via Foreign Currency Convertible Bonds (FCCBs).The resolution was passed during the 1st Extra-Ordinary General Meeting of FY 2025-26 held on December 17, 2025.The issuance may be conducted in one or more tranches in various currencies including USD and INR.The Finance Committee will determine the final terms, pricing, and conversion details at the time of issuance.
👀 கவனிக்க வேண்டியவை
Investors should monitor the subsequent announcement regarding the conversion price and interest rate of the FCCBs to assess potential equity dilution. The successful approval indicates strong management intent to scale operations through international capital markets.
Share India Shareholders Approve Fundraise via FCCBs with 99.81% Majority
Share India Securities Limited has received overwhelming shareholder approval to raise capital through the issuance of Foreign Currency Convertible Bonds (FCCBs). The special resolution was passed during the Extra-ordinary General Meeting held on December 17, 2025, with 99.81% of the votes cast in favor. This capital infusion is likely intended to support the company's growth and expansion plans in the financial services sector. The high level of support from both promoters and public shareholders indicates strong confidence in the management's strategic direction.
முக்கிய அம்சங்கள்
Shareholders approved the issuance of Foreign Currency Convertible Bonds (FCCBs) via a special resolution.The resolution passed with a 99.81% majority, with 140,030,546 votes in favor and only 265,453 against.Total voter turnout represented 64.11% of the total outstanding shares of the company.Promoter and Promoter Group voted 100% in favor of the resolution with 95,010,004 shares.Public Institutional support was also high at 98.58% in favor of the fundraise.
👀 கவனிக்க வேண்டியவை
Investors should monitor subsequent announcements regarding the total amount to be raised and the specific conversion terms of the FCCBs. The successful approval is a positive signal for the company's liquidity and growth prospects.
Thyrocare Appoints Dr. Ramesh Kinha as Chief Operating Officer
Thyrocare Technologies has appointed Dr. Ramesh Kinha as its Chief Operating Officer (COO) effective December 18, 2025. Dr. Kinha is a seasoned professional with over 17 years of experience in the healthcare and diagnostics sector, having previously served as Group Director at Vijaya Diagnostic Centre. His extensive background includes leadership roles at major industry players such as Metropolis Healthcare and SRL Ltd. This appointment is expected to strengthen Thyrocare's operational leadership and strategic execution in the competitive diagnostics market.
முக்கிய அம்சங்கள்
Dr. Ramesh Kinha appointed as Chief Operating Officer effective December 18, 2025Brings over 17 years of experience across major diagnostic firms including Metropolis, SRL, and Vijaya DiagnosticHolds an MBBS, MD in Pathology, and senior management certifications from IIM Nagpur and ISBExpertise spans laboratory services, quality assurance, and organization-wide strategic operations
👀 கவனிக்க வேண்டியவை
Investors should monitor how Dr. Kinha's operational expertise impacts the company's efficiency and service quality. This is a positive leadership addition given his deep industry experience and medical background.
Waaree Renewable Subsidiary Signs 300 MW Solar PPA with Global Tech Giant
Sunsational Power Private Limited, a wholly owned subsidiary of Waaree Renewable Technologies, has signed a long-term Power Purchase Agreement (PPA). The agreement is for a 300 MW Inter-State Transmission System (ISTS) connected solar power project. The counterparty is a leading global tech giant with significant and growing energy requirements in India. This deal provides long-term revenue visibility and strengthens the company's position in the renewable energy sector.
முக்கிய அம்சங்கள்
Signed a long-term PPA for a 300 MW ISTS-connected solar power projectAgreement executed by 100% subsidiary Sunsational Power Private LimitedCounterparty is a leading global tech giant with expanding Indian operationsProject utilizes Inter-State Transmission System (ISTS) for power evacuation
👀 கவனிக்க வேண்டியவை
Investors should view this as a significant positive development for long-term revenue growth and order book strength. Monitor for updates on project execution timelines and specific tariff details if disclosed.
Religare Subsidiary Care Health Insurance Fined ₹1 Crore by IRDAI
Care Health Insurance Limited (CHIL), a material subsidiary of Religare Enterprises, has been penalized ₹1 crore by the IRDAI for various regulatory violations. The penalty follows an inspection conducted in 2021 which identified breaches in Third Party Administrator (TPA) health services and corporate governance guidelines. In addition to the monetary fine, the regulator issued warnings and advisories regarding financial statement preparation and policyholder interest protection. While the financial impact is limited, the regulatory focus on governance at a key subsidiary is noteworthy for shareholders.
முக்கிய அம்சங்கள்
IRDAI imposed a ₹1 crore penalty on Care Health Insurance Limited (CHIL) for regulatory non-compliance.Violations relate to TPA Health Services regulations and Corporate Governance guidelines identified during a 2021 inspection.The regulator also issued formal warnings and advisories concerning financial reporting and policyholder protection.The penalty is payable by CHIL and will be reflected in the consolidated financial statements of Religare Enterprises.The order was received on December 15, 2025, following a review of the company's submissions.
👀 கவனிக்க வேண்டியவை
Investors should monitor for any further governance-related disclosures, as repeated regulatory friction can impact the valuation of the insurance subsidiary. The immediate financial impact of ₹1 crore is negligible relative to Religare's overall scale.
Waaree Energies Incorporates Two Step-Down Subsidiaries for Power Projects
Waaree Energies has announced the incorporation of two new step-down subsidiaries, Windora Energy Private Limited and Agni Vayu Energy Private Limited, through its wholly-owned subsidiary Waaree Forever Energies Private Limited. Both companies were incorporated on December 16, 2025, and will operate as Independent Power Producers (IPPs). These entities are specifically designed to facilitate and hold future power projects under the IPP framework. While currently having nil turnover, this move signals the company's intent to scale its power generation and project holding capacity.
முக்கிய அம்சங்கள்
Incorporation of Windora Energy and Agni Vayu Energy as 100% step-down subsidiaries.The new entities will function as Independent Power Producers (IPPs) for specific projects.Both subsidiaries were registered on December 16, 2025, with the Registrar of Companies, Mumbai.Waaree Forever Energies Private Limited holds 100% share capital in both new entities.
👀 கவனிக்க வேண்டியவை
This is a routine but positive expansion of the corporate structure to support future project execution. Investors should track the commencement of operations and project wins under these new entities.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
